NCT05847439View on ClinicalTrials.gov

A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]BMS-986419

Specified dose on specified days

Trial Locations (1)

53704-2526

Labcorp Clinical Research Unit - Madison, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05847439 - A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants | Biotech Hunter | Biotech Hunter